SCHEMBL4773753

SCHEMBL4773753

COc1ccc(-c2cc3ccccc3c(-n3ccnc3)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 4/20 0.54
KMT2A Q03164 3/20 0.54
TDP1 Q9NUW8 3/20 0.54
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
CYP19A1 P11511 3/20 0.49
CYP11B1 P15538 2/20 0.49
CYP11B2 P19099 2/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 5/20 0.46
MAPT P10636 4/20 0.46
HPGD P15428 3/20 0.46
ACACA Q13085 1/20 0.46
HTT P42858 1/20 0.46
DHODH Q02127 1/20 0.46
TP53 P04637 3/20 0.45
MEN1 O00255 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4770246 0.99 ALDH1A1 (0.53) ALDH1A1KDM4EKMT2ATDP1MAOA
SCHEMBL11820505 0.86 CYP3A4 (0.53) ALDH1A1KDM4EKMT2ATDP1MAOA
SCHEMBL14103054 0.84 DHODH (0.48) ALDH1A1KDM4EKMT2ATDP1MAOA
SCHEMBL25098816 0.76 NPC1 (0.59) ALDH1A1KDM4EKMT2ATDP1NPC1
SCHEMBL11814515 0.74 CYP3A4 (0.52) ALDH1A1KDM4EKMT2ATDP1CYP19A1
SCHEMBL4770812 0.74 HRH4 (0.56) KDM4EKMT2ANPC1RAB9AHPGD
SCHEMBL4772233 0.73 MERTK (0.55) ALDH1A1KDM4ETDP1NPC1RAB9A
SCHEMBL4771287 0.73 ROCK2 (0.60) ALDH1A1KDM4EKMT2ANPC1RAB9A
SCHEMBL13443764 0.73 NPC1 (0.59) ALDH1A1KDM4EKMT2ATDP1NPC1
SCHEMBL4773258 0.73 KDM4E (0.66) ALDH1A1KDM4EKMT2ATDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US claimed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP claimed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
US-6875761-B2 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. (JP) 2005-04-05 US disclosed
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. 2004-10-14 US disclosed
US-6790844-B2 MUSCLE RELAXANTS; ANTISEROTONINE AGENT EISAI CO., LTD (JP) 2004-09-14 US disclosed
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US disclosed
US-6340759-B1 ANTISPASMODIC AGENTS EISAI CO., LTD. (JP) 2002-01-22 US disclosed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013460-A1 Condensed pyridine compound MUSK, HTR1A, PAX3 ALDH1A1 2989/4885KDM4E 1050/4885KMT2A 1240/4885
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives MUSK, HTR1A, RYR1 ALDH1A1 1071/4885KDM4E 1058/4885KMT2A 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.